Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results

January 8, 2024

https://www.globenewswire.com/news-release/2024/01/08/2805448/0/en/Neuronetics-Reports-Preliminary-Fourth-Quarter-and-Fiscal-Year-2023-Financial-Results.html

MALVERN, Pa., Jan. 08, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ:STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, today announced certain preliminary unaudited fourth quarter and full year 2023 results.

Read more at globenewswire.com

Related news for (STIM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.